Literature DB >> 10070585

Predictors of failure to return for HIV test result and counseling by test site type.

F Molitor1, R A Bell, S R Truax, J D Ruiz, R K Sun.   

Abstract

The objective of this study was to determine the primary predictors of failure to return (FTR) for HIV test results and counseling by test site type from among those variables collected during the pretest, risk assessment session. The study sample consisted of 366,280 clients tested for HIV antibodies over an 18-month period at publicly funded testing sites throughout California. The FTR rate for the entire sample was 16.4%. The most significant predictor of FTR was the site type at which resting took place, with those testing at sexually transmitted disease clinics four times, and mobile testing clients over three times, more likely to fail to return than alternative test site clients. Independent predictors of FTR differed dramatically across the types of testing sites examined. Implications of these results for devising site-specific counseling strategies to reduce FTR are examined and possible effects on FTR of more rapid testing procedures and home testing are considered. Suggestions for future research are outlined.

Entities:  

Mesh:

Year:  1999        PMID: 10070585

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  11 in total

1.  Testing for HIV infection in the United States.

Authors:  Lindsey L Wolf; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

Review 2.  The utilization of testing and counseling for HIV: a review of the social and behavioral evidence.

Authors:  Carla Makhlouf Obermeyer; Michelle Osborn
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

3.  Results from a multiple morbidities testing program offering rapid HIV testing bundled with hepatitis and sexually transmitted infection testing.

Authors:  Grace L Reynolds; Dennis G Fisher; Lucy E Napper; Kimberly A Marsh; Christine Willey; Ryan Brooks
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

Review 4.  Rapid diagnostic HCV antibody assays.

Authors:  Bryce D Smith; Amy Jewett; Jan Drobeniuc; Saleem Kamili
Journal:  Antivir Ther       Date:  2012-12-07

5.  Using motivational interviewing in HIV field outreach with young African American men who have sex with men: a randomized clinical trial.

Authors:  Angulique Y Outlaw; Sylvie Naar-King; Jeffrey T Parsons; Monique Green-Jones; Heather Janisse; Elizabeth Secord
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

6.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

7.  Individual-level predictors of nonparticipation and dropout in a life-skills HIV prevention program for adolescents in foster care.

Authors:  Ronald G Thompson; Wendy F Auslander; Dana Alonzo
Journal:  AIDS Educ Prev       Date:  2012-06

8.  Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing.

Authors:  Henry D Anaya; Tuyen Hoang; Joya F Golden; Matthew Bidwell Goetz; Allen Gifford; Candice Bowman; Teresa Osborn; Douglas K Owens; Gillian D Sanders; Steven M Asch
Journal:  J Gen Intern Med       Date:  2008-04-18       Impact factor: 5.128

9.  HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.

Authors:  Thomas J Stopka; Clark Marshall; Ricky N Bluthenthal; David S Webb; Steven R Truax
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

Review 10.  The check-up: in-person, computerized, and telephone adaptations of motivational enhancement treatment to elicit voluntary participation by the contemplator.

Authors:  Denise D Walker; Roger A Roffman; Joseph F Picciano; Robert S Stephens
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.